Eargo, Inc. EAR
We take great care to ensure that the data presented and summarized in this overview for Eargo, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in EAR
Top Purchases
Top Sells
About EAR
Eargo, Inc., a medical device company, engages in enhancing the quality of life of people with hearing loss in the United States. The company markets and sells hearing aids. It sells its products direct-to-consumer and through omni-channel. The company was formerly known as Aria Innovations, Inc. and changed its name to Eargo, Inc. in November 2014. Eargo, Inc. was incorporated in 2010 and is headquartered in San Jose, California.
Insider Transactions at EAR
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|
Feb 16
2024
|
William Brownie Interim CEO & COO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
296
-56.42%
|
-
|
|
Feb 16
2024
|
David James Wu Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
25,463
-100.0%
|
-
|
|
Feb 16
2024
|
Mark Thorpe CFO & CAO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
32
-100.0%
|
-
|
|
Nov 29
2023
|
Mark Thorpe CFO & CAO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,029
-96.98%
|
$2,058
$2.59 P/Share
|
|
Nov 20
2023
|
Adam Laponis Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
33
-11.34%
|
$66
$2.6 P/Share
|
|
Nov 17
2023
|
Adam Laponis Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
19
-6.13%
|
$38
$2.56 P/Share
|
|
Nov 17
2023
|
William Brownie Interim CEO & COO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
14
-4.52%
|
$28
$2.56 P/Share
|
|
Nov 17
2023
|
Mark Thorpe CFO & CAO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
3
-0.28%
|
$6
$2.56 P/Share
|
|
Nov 15
2023
|
Adam Laponis Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,842
-90.17%
|
$5,684
$2.55 P/Share
|
|
Nov 13
2023
|
William Brownie Interim CEO & COO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
6,469
-71.79%
|
$12,938
$2.56 P/Share
|
|
Aug 17
2023
|
Mark Thorpe CFO & CAO |
SELL
Open market or private sale
|
Direct |
3
-0.28%
|
$9
$3.23 P/Share
|
|
Aug 17
2023
|
Adam Laponis Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
19
-0.6%
|
$57
$3.24 P/Share
|
|
Aug 17
2023
|
William Brownie Interim CEO & COO |
SELL
Open market or private sale
|
Direct |
1,514
-9.14%
|
$4,542
$3.22 P/Share
|
|
May 17
2023
|
William Brownie Interim CEO & COO |
SELL
Open market or private sale
|
Direct |
14
-0.17%
|
$56
$4.69 P/Share
|
|
May 17
2023
|
Christian Gormsen President and CEO |
SELL
Open market or private sale
|
Direct |
58
-0.95%
|
$232
$4.69 P/Share
|
|
May 17
2023
|
Mark Thorpe CFO & CAO |
SELL
Open market or private sale
|
Direct |
3
-0.28%
|
$12
$4.69 P/Share
|
|
May 17
2023
|
Adam Laponis Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
19
-0.6%
|
$76
$4.69 P/Share
|
|
Feb 17
2023
|
Adam Laponis Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
21
-0.65%
|
$147
$7.37 P/Share
|
|
Feb 17
2023
|
Christian Gormsen President and CEO |
SELL
Open market or private sale
|
Direct |
64
-1.03%
|
$448
$7.37 P/Share
|
|
Feb 17
2023
|
William Brownie Interim CEO & COO |
SELL
Open market or private sale
|
Direct |
15
-0.18%
|
$105
$7.37 P/Share
|